New York State Common Retirement Fund cut its holdings in shares of Xometry, Inc. (NASDAQ:XMTR - Free Report) by 12.3% in the 3rd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 948,366 shares of the company's stock after selling 132,402 shares during the period. New York State Common Retirement Fund owned approximately 1.92% of Xometry worth $17,421,000 at the end of the most recent reporting period.
A number of other institutional investors and hedge funds also recently made changes to their positions in XMTR. State Board of Administration of Florida Retirement System boosted its holdings in Xometry by 22.1% during the first quarter. State Board of Administration of Florida Retirement System now owns 11,840 shares of the company's stock worth $200,000 after purchasing an additional 2,140 shares during the last quarter. Vanguard Group Inc. grew its holdings in shares of Xometry by 2.0% in the first quarter. Vanguard Group Inc. now owns 3,877,346 shares of the company's stock valued at $65,488,000 after acquiring an additional 76,976 shares in the last quarter. Texas Capital Bank Wealth Management Services Inc purchased a new stake in shares of Xometry during the first quarter valued at approximately $169,000. Clearbridge Investments LLC lifted its holdings in Xometry by 20.7% during the first quarter. Clearbridge Investments LLC now owns 1,270,631 shares of the company's stock worth $21,461,000 after acquiring an additional 217,939 shares during the period. Finally, Sylebra Capital LLC grew its stake in Xometry by 1,005.3% in the 1st quarter. Sylebra Capital LLC now owns 644,262 shares of the company's stock valued at $10,882,000 after purchasing an additional 585,971 shares during the period. Institutional investors and hedge funds own 97.31% of the company's stock.
Insider Buying and Selling at Xometry
In other Xometry news, CTO Matthew Leibel sold 3,400 shares of the company's stock in a transaction that occurred on Friday, September 13th. The stock was sold at an average price of $18.45, for a total value of $62,730.00. Following the completion of the sale, the chief technology officer now owns 82,918 shares of the company's stock, valued at $1,529,837.10. This represents a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. Company insiders own 16.79% of the company's stock.
Wall Street Analysts Forecast Growth
A number of brokerages recently weighed in on XMTR. Royal Bank of Canada boosted their price target on shares of Xometry from $23.00 to $27.00 and gave the stock a "sector perform" rating in a report on Wednesday. Citigroup raised their price target on shares of Xometry from $25.00 to $33.00 and gave the stock a "buy" rating in a research note on Wednesday. Craig Hallum boosted their target price on Xometry from $20.00 to $30.00 and gave the company a "buy" rating in a research note on Wednesday. UBS Group boosted their price objective on Xometry from $20.00 to $22.00 and gave the company a "neutral" rating in a research note on Wednesday. Finally, The Goldman Sachs Group lifted their target price on shares of Xometry from $24.00 to $28.00 and gave the stock a "buy" rating in a research note on Wednesday. One research analyst has rated the stock with a sell rating, two have assigned a hold rating and four have issued a buy rating to the stock. Based on data from MarketBeat, the company presently has an average rating of "Hold" and an average price target of $26.29.
Get Our Latest Research Report on XMTR
Xometry Price Performance
Shares of NASDAQ XMTR traded up $4.78 during midday trading on Wednesday, hitting $30.62. 1,588,701 shares of the company's stock were exchanged, compared to its average volume of 603,439. The company has a current ratio of 4.64, a quick ratio of 4.60 and a debt-to-equity ratio of 0.89. The business's fifty day moving average price is $19.14 and its two-hundred day moving average price is $16.55. The company has a market cap of $1.51 billion, a price-to-earnings ratio of -28.34 and a beta of 0.55. Xometry, Inc. has a 12-month low of $11.08 and a 12-month high of $38.74.
Xometry (NASDAQ:XMTR - Get Free Report) last released its quarterly earnings results on Tuesday, November 5th. The company reported ($0.12) EPS for the quarter, topping analysts' consensus estimates of ($0.21) by $0.09. The business had revenue of $141.70 million during the quarter, compared to analysts' expectations of $137.17 million. Xometry had a negative net margin of 10.53% and a negative return on equity of 10.75%. As a group, research analysts forecast that Xometry, Inc. will post -0.81 EPS for the current fiscal year.
Xometry Profile
(
Free Report)
Xometry, Inc operates an online marketplace that enables buyers to source custom-manufactured parts and assemblies in the United States and internationally. It provides computer numerical control manufacturing, sheet metal forming, and sheet cutting; 3D printing, including fused deposition modeling, direct metal laser sintering, PolyJet, stereolithography, selective laser sintering, binder jetting, carbon digital light synthesis, multi jet fusion, and lubricant sublayer photo-curing; and die casting, stamping, injection molding, urethane casting, tube cutting, and tube bending, as well as finishing services, rapid prototyping, and high-volume production services.
See Also
Before you consider Xometry, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Xometry wasn't on the list.
While Xometry currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Market downturns give many investors pause, and for good reason. Wondering how to offset this risk? Click the link below to learn more about using beta to protect yourself.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.